Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Halothane hepatitis: toxicity or hypersensitivity?

B A Chapman, V G Laurenson, H B Cook

    The New Zealand Medical Journal
    |September 25, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study.

    International journal of clinical practice·2013
    Same author

    Two cases of severe liver injury possibly related to 5-fluorouracil and calcium folinate.

    Internal medicine journal·2007
    Same author

    Ancient polyploidization predating divergence of the cereals, and its consequences for comparative genomics.

    Proceedings of the National Academy of Sciences of the United States of America·2004
    Same author

    Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease.

    Alimentary pharmacology & therapeutics·2003
    Same author

    Influence of haemochromatosis gene mutations on treatment outcomes in patients with hepatitis C.

    Internal medicine journal·2001
    Same author

    Interferon-alpha2a/ribaviran versus interferon-alpha2a alone for the retreatment of hepatitis C patients who relapse after a standard course of interferon.

    The New Zealand medical journal·2001
    Same journal

    Reed diffusers: a potential cause of poisoning in young children in New Zealand.

    The New Zealand medical journal·2026
    Same journal

    Stuffy nights: elevated bedroom carbon dioxide concentrations indicate inadequate ventilation in Wellington homes.

    The New Zealand medical journal·2026
    Same journal

    Cautionary tale of how sodium polystyrene sulfonate caused gut necrosis: a case report.

    The New Zealand medical journal·2026
    Same journal

    Emergency lateral canthotomy and cantholysis for acute globe subluxation.

    The New Zealand medical journal·2026
    Same journal

    Liberation of an incarcerated tibialis posterior tendon following a posterior malleolar ankle fracture: a case report.

    The New Zealand medical journal·2026
    Same journal

    Implementing a cultural safety training plan across medical colleges in Aotearoa New Zealand-looking back, and looking forward.

    The New Zealand medical journal·2026
    See all related articles

    A patient experienced severe hepatitis after halothane anesthesia. Subsequent anesthesia without halothane, even with routine equipment, did not cause recurrence, suggesting halothane as the cause of liver injury.

    Area of Science:

    • Anesthesiology
    • Hepatology
    • Toxicology

    Background:

    • Halothane is an inhalation anesthetic agent.
    • Drug-induced liver injury (DILI) is a significant concern in anesthesia.
    • Identifying causative agents is crucial for patient safety.

    Observation:

    • A 32-year-old female developed severe hepatitis (serum bilirubin 544 µmol/L) one week post-halothane anesthesia.
    • Six months later, anesthesia via a halothane-free circuit was uneventful.
    • A year later, a non-halothane anesthetic using routine equipment, after oxygen flushing, led to fever and abnormal liver function tests.

    Findings:

    • The patient's severe hepatitis resolved after the initial halothane exposure.
    • Re-exposure to anesthesia, even with potentially contaminated equipment (routine circuit), did not trigger a similar hepatic event when halothane was absent.

    Related Experiment Videos

  • The transient fever and abnormal liver function tests after the third anesthetic suggest a possible mild inflammatory response or residual sensitivity, but not severe hepatitis.

    • Implications:

    • This case highlights the potential for halothane-induced liver injury.
    • It suggests that halothane-free anesthesia is safe for patients with a history of halothane hepatitis.
    • Thorough equipment cleaning and flushing protocols may mitigate risks associated with trace anesthetic residues.